drugset / Trial / NCT00772291

Chronic Pain Management After Herniorraphy

NCT00772291

Phase 3 Completed 140 enrolled Erasmus Medical Center
RandomizedParallel-groupQuadruple-blindTreatment

Summary

Nowadays, chronic pain mainly as a result of iatrogenic nerve damage is generally considered as the most frequent complication after inguinal hernia surgery. The primary objective of this randomised double-blind placebo-controlled trial is to investigate whether pregabalin reduces pain in patients with chronic pain of neuropathic origin after herniorraphy.

Timeline

Start
2007-05
Primary completion
2010-08
Completion
2010-10

Drugs

EvaluationDrugModalityDoseRoute
Comparator Pregabalin Small molecule 150 mg
Comparator Pregabalin Small molecule 600 mg

Indications